Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2200210	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Import Drug Application	2022-12-23		view
JXSL2200209	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Import Drug Application	2022-12-23		view
JXSL2200211	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Import Drug Application	2022-12-23		view
JXSL2300064	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Import Drug Application	2023-04-05		view
JXSB2300099	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2023-08-11	Amgen Inc	view
JXSB2300100	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2023-08-12	Amgen Inc	view
JXSB2300116	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2023-09-28	Amgen Inc	view
JXSB2300152	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2023-12-08	Amgen Inc	view
JXSL2400047	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Import Drug Application	2024-02-21		view
JXSL2400118	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Import Drug Application	2024-07-02		view
JXSB2400143	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2024-11-09	Amgen Inc	view
JXSB2400147	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2024-11-19	Amgen Inc	view
JXSB2400146	AMG 451	Rocatinlimab	Injection	Biological Products(1)	Supplementary Application	2024-11-19	Amgen Inc	view